(Q33936187)

English

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Thomas Macdonald

object named as

Thomas M MacDonald

6

0 references

object named as

Frank M Sullivan

5

0 references

2

object named as

Shah Ebrahim

1 reference

Europe PubMed Central

30 July 2017

author name string

Li Wei

1

1 reference

Europe PubMed Central

30 July 2017

Christopher Bartlett

3

1 reference

Europe PubMed Central

30 July 2017

Peter D Davey

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

24 March 2005

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

330

1 reference

Europe PubMed Central

30 July 2017

821

1 reference

Europe PubMed Central

30 July 2017

7495

1 reference

Europe PubMed Central

30 July 2017

The causes and effects of socio-demographic exclusions from clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Regional repositories, reintermediation and the new GMS contract: cardiovascular disease in Tayside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Optimal strategies for identifying patients with myocardial infarction in general practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

A strategy to reduce cardiovascular disease by more than 80%

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

A comparison of observational studies and randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=556073

5 July 2018

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15790616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravviv

1 reference

https://pubmed.ncbi.nlm.nih.gov/15790616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deprivation and health in Scotland

1 reference

https://pubmed.ncbi.nlm.nih.gov/15790616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confounding by indication

1 reference

https://pubmed.ncbi.nlm.nih.gov/15790616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.38398.408032.8F

1 reference

https://api.fatcat.wiki/v0/release/vxq5c2q4sjdvxnh3bdag7at3g4

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_vxq5c2q4sjdvxnh3bdag7at3g4

1 reference

https://api.fatcat.wiki/v0/release/vxq5c2q4sjdvxnh3bdag7at3g4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/vxq5c2q4sjdvxnh3bdag7at3g4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/vxq5c2q4sjdvxnh3bdag7at3g4

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33936187&oldid=1820328426"